Análisis de costo efectivi dad de everolimus más tacrolimus y prednisolona comparado con tacrolimus más prednisolona para la inmunosupresión de mantenimiento en el trasplante hepático en Colombia

Orozco Ramírez, Luis Esteban; Sánchez Higuita, Edel Laura; Castro García, Paula Andrea; Contreras Ortiz, Javier Orlando.
Bogotá; IETS; mayo 2016. 51 p.
Monografia em Espanhol | LILACS, BRISA | ID: biblio-837426

Documentos relacionados

  1. Fund Black scientists.
  2. Sirolimus Versus Tacrolimus as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation.
  3. Development and Impact of an Institutional Enhanced Recovery Program on Opioid Use, Length of Stay, and Hospital Costs Within an Academic Medical Center: A Cohort Analysis of 7774 Patients.
  4. Attitude changes in prescribing intravenous iron supplementation in different settings at a hospital consortium in Italy.
  5. Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals.
  6. From scientific discovery to cures: bright stars within a galaxy.
  7. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
  8. Electronic cigarette substitution in the experimental tobacco marketplace: A review.
  9. [The cost of pulmonary thromboembolism treatment].
  10. Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands.